Search research articles
Contact Us
Filters
Showing results (71-80 of 90) with videos related to
Page
of 9
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2008
Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer
F Puglisi, G G Cardellino, D Crivellari, et al.
Lancet (London, England)
|
May 11, 1996
Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group
C Hürny, J Bernhard, A S Coates, et al.
Lancet (London, England)
|
June 24, 2000
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
S Aebi, S Gelber, M Castiglione-Gertsch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 26, 1998
Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI
O Pagani, A O'Neill, M Castiglione, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 11, 2012
Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report
P Karlsson, B F Cole, B H Chua, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 1, 1997
Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI
A Goldhirsch, R D Gelber, M Castiglione, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2007
CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials
A Keshaviah, S Dellapasqua, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2006
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)
B C Pestalozzi, D Zahrieh, K N Price, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2011
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX
S Aebi, Z Sun, D Braun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 18, 2011
Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer
P Karlsson, Z Sun, D Braun, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 90) with videos related to
Sort By:
Page
of 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2008
Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer
F Puglisi, G G Cardellino, D Crivellari, et al.
Lancet (London, England)
|
May 11, 1996
Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group
C Hürny, J Bernhard, A S Coates, et al.
Lancet (London, England)
|
June 24, 2000
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
S Aebi, S Gelber, M Castiglione-Gertsch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 26, 1998
Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI
O Pagani, A O'Neill, M Castiglione, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 11, 2012
Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report
P Karlsson, B F Cole, B H Chua, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 1, 1997
Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI
A Goldhirsch, R D Gelber, M Castiglione, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2007
CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials
A Keshaviah, S Dellapasqua, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2006
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)
B C Pestalozzi, D Zahrieh, K N Price, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2011
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX
S Aebi, Z Sun, D Braun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 18, 2011
Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer
P Karlsson, Z Sun, D Braun, et al.
Page
of 9